Doctors More Cautious Now When Prescribing Opioids to Kids

There's been a steady decline in opioid prescriptions for children and teens in the United States since 2012, a new study reveals.
"Understanding patterns of opioid use in children and adolescents is important because use in early life has been associated with a higher likelihood of opioid misuse in the future," said the study's first author, Joshua Gagne. He's with the division of pharmacoepidemiology and pharmacoeconomics at Brigham and Women's Hospital in Boston.
Prior studies found that the rate of hospitalizations due to opioid poisonings nearly doubled among American children and adolescents between 1997 and 2012.
"We sought to examine more recent opioid prescribing trends in younger populations as this age group has been consistently understudied," Gagne said in a hospital news release.
The researchers examined 2004-2017 data from a commercial insurance provider. They found that in 2004, an average of 3 in every 1,000 children under age 18 had received an outpatient opioid prescription in a given month.
Between 2009 and 2012, that rose to 4 in 1,000. By 2017, however, the number had dropped to 2 per 1,000 children, according to the study.
"These results show that prescription opioids dispensed to children and adolescents have been decreasing since 2012," the study authors wrote.
"Despite the downward trends for opioid prescriptions, the frequency of opioid use remains high given the risks associated with these medications in younger populations," the researchers concluded.
2026-08-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Deméter Enters China with a Stress-Focused Pitch
-
A White Storm Sweeps Through “Golden October”: China’s Titanium Dioxide Giants Join Forces in a Battle for SurvivalA White Storm Sweeps Through “Golden October”: China’s Titanium Dioxide Giants Join Forces in a Battle for Survival
-
Can Lotte Chemical's Four Growth Pillars Support Its New Valuation After Spinning Off Basic Chemicals?
-
Russia’s Farm Trade Model Shows Strain
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
-
India Issues Final Anti-Dumping Ruling on Chinese TDQ, with Duties Up to US$549 per Ton
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
Brazil Confirms 32 Methanol Poisoning Cases Linked to Contaminated Alcoholic Beverages
-
EFSA Evaluates Extended Use of Pasteurised Akkermansia muciniphila as a Novel Food
Recommend Reading
-
EFSA Confirms Safety of β-Amylase Produced from Barley for Food Manufacturing Use
-
EFSA Unable to Confirm Safety of Fusarium flavolapis Fungal Protein as a Novel Food
-
EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040
-
Middle East Conflict Hits China Seafood Trade
-
Hormuz Closure Raises Cold-Chain Risk
-
Business Society’s August 13, 2026 Phenol Market Outlook: Continuing Downward Trend
-
Business Society’s Market Outlook for Ammonium Sulfate on August 11, 2026: Fluctuating and Declining
-
Business Society’s August 13, 2026 Melamine Market Outlook: Clearly Downward
-
Business Society’s Market Outlook for Ethylene Glycol on August 12, 2026: Volatile
-
MTBE Market Prices Fluctuate and Decline
- Hot Searches
- chlorfenapyr insecticide
- trisodium phosphate where to buy
- best igf-1 lr3 suppliers
- polypropylene cost
- can you purchase formaldehyde
- lldpe products
- mono propylene glycol for sale
- perchloroethylene msds
- kroton oil
- peptide retatrutide where to buy
- glp-1 retatrutide where to buy
- betaine+skincare+supplier